Follow
Manish Aghi
Manish Aghi
Unknown affiliation
Verified email at neurosurg.ucsf.edu
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
92072021
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ...
Cancer cell 22 (1), 21-35, 2012
5532012
Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in GlioblastomaAutophagy Mediates Resistance to Antiangiogenic Therapy
YL Hu, M DeLay, A Jahangiri, AM Molinaro, SD Rose, WS Carbonell, ...
Cancer research 72 (7), 1773-1783, 2012
4722012
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation
MK Aghi, BS Carter, GR Cosgrove, RG Ojemann, S Amin-Hanjani, ...
Neurosurgery 64 (1), 56-60, 2009
4422009
Impact of extent of resection for recurrent glioblastoma on overall survival
O Bloch, SJ Han, S Cha, MZ Sun, MK Aghi, MW McDermott, MS Berger, ...
Journal of neurosurgery 117 (6), 1032-1038, 2012
4362012
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
S Müller, G Kohanbash, SJ Liu, B Alvarado, D Carrera, A Bhaduri, ...
Genome biology 18, 1-14, 2017
4152017
Oncolytic viral therapies–the clinical experience
M Aghi, RL Martuza
Oncogene 24 (52), 7802-7816, 2005
3732005
Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
H Wakimoto, S Kesari, CJ Farrell, WT Curry Jr, C Zaupa, M Aghi, T Kuroda, ...
Cancer research 69 (8), 3472-3481, 2009
3682009
Prodrug activation enzymes in cancer gene therapy
M Aghi, F Hochberg, XO Breakefield
The journal of gene medicine 2 (3), 148-164, 2000
2602000
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
MA Vogelbaum, S Jost, MK Aghi, AB Heimberger, JH Sampson, PY Wen, ...
Neurosurgery 70 (1), 234-244, 2012
2402012
Biology of angiogenesis and invasion in glioma
MC Tate, MK Aghi
Neurotherapeutics 6 (3), 447-457, 2009
2382009
Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed …
AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ...
JAMA oncology 6 (4), 495-503, 2020
2362020
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes
M Aghi, KS Cohen, RJ Klein, DT Scadden, EA Chiocca
Cancer research 66 (18), 9054-9064, 2006
2252006
Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistancec-Met Mediates Antiangiogenic Therapy Resistance
A Jahangiri, M De Lay, LM Miller, WS Carbonell, YL Hu, K Lu, MW Tom, ...
Clinical Cancer Research 19 (7), 1773-1783, 2013
2102013
Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy
YL Hu, A Jahangiri, M DeLay, MK Aghi
Cancer research 72 (17), 4294-4299, 2012
2082012
Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
O Bloch, CA Crane, Y Fuks, R Kaur, MK Aghi, MS Berger, NA Butowski, ...
Neuro-oncology 16 (2), 274-279, 2014
1962014
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
RF Barajas Jr, JJ Phillips, R Parvataneni, A Molinaro, E Essock-Burns, ...
Neuro-oncology 14 (7), 942-954, 2012
1942012
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy
CM Kramm, M Chase, U Herrlinger, A Jacobs, PA Pechan, NG Rainov, ...
Human gene therapy 8 (17), 2057-2068, 1997
1921997
Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine …
M Aghi, TC Chou, K Suling, XO Breakefield, EA Chiocca
Cancer research 59 (16), 3861-3865, 1999
1801999
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies
M Aghi, TC Cho, EA Chiocca, CM Kramm, XO Breakefield
JNCI: Journal of the National Cancer Institute 90 (5), 370-380, 1998
1781998
The system can't perform the operation now. Try again later.
Articles 1–20